Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2023.198 | Analysis of relationships between housing environmental exposures and metabolic profiles of residents living in sub-divided flat unit in Hong Kong |
Prof. Wong Eliza Lai-Yi 黃麗儀 |
| 2022.367 | Analysis of plasma Epstein-Barr virus (EBV) DNA and EBV antibody for early detection of nasopharyngeal carcinoma and protocol optimisation | Dr. LAM Wai Kei Jacky |
| 2009.233 | Analysis of Nanoquartz Deposits in the Lung Cancer Tissues of Non-Smoking Women Exposed to Coal Combustion Emissions | Prof. Tian Linwei |
| 2020.719 | Analysis of microbial cell-free nucleic acids in patients with sepsis | Prof. LAM Jacky Wai Kei |
| 2011.464 | Analysis of magnetic resonance imaging of the nasopharynx in patients with suspected and biopsy proven nasopharyngeal carcinoma | Prof. KING Ann |
| 2020.506 | Analysis of Hepatocellular Carcinoma Stereotactic Body Radiation Therapy Dose Prescription Method using Uncomplicated Tumour Control Probability Model | Mr. CHEUNG Michael |
| 2018.404 | Analysis of Genetic Basis of Cardiovascular Disease |
Prof. LO Cecilia Wen Ya 羅聞亞 |
| 2012.156 | Analysis of estrogen receptor beta isoforms in human thyroid cancer | Professor Vlantis Alexander C |
| 2022.688 | Analysis of Elbow, Wrist, and Hand Pain Among Volleyball Players in Hong Kong |
Dr. WONG Clara Wing Yee 黃詠儀 |
| 2005.434 | Analysis of Clinical Profiles of Chinese Patients with Normal Tension Glaucoma | LEUNG Yu Lung Dexter |
| 2018.277 | Analysis of clinical characteristics of CMV retinitis in immunosuppressed cases (a retrospective cohort study) |
Dr. HO Mary 何璟穎 |
| 2015.584 | Analysis of circulating nucleic acids of blood cell origin |
Prof. CHIU Rossa Wai Kwun 趙慧君 |
| 2022.436 | Analysis of brain-derived cell-free nucleic acids in patients with acute ischemic stroke |
Dr. LAM Wai Kei Jacky 林偉棋 |
| 2022.437 | Analysis of brain-derived cell-free DNA in plasma and cerebrospinal fluid |
Dr. LAM Jacky Wai Kei 林偉棋 |
| 2013.218 | Analysing patient flow and capacity in the Emergency Department: a simulation study | Prof Graham Colin |
| 2014.008 | Analyses of the temporal trends of CD4 changes following antiretroviral therapy in HIV infection | Prof Lee Shui Shan |
| 2002.481 | Analgesic Efficacy of Parecoxib Sodium Following Hepatic Resection - A Prospective, Randomized, Placebo-Controlled Trial | Dr. Chan K.C. Simon |
| 2007.466 | Analgesic Efficacy of Intra-Articular Magnesium after Arthroscopic Anterior Cruciate Ligament Reconstruction | Dr Tsang Kristie HS |
| 2002.421 | Analgesic Efficacy and Pre-emptive Analgesia of Parecoxib Sodium in Gynaecological Surgery | Dr. Lim Huey Sing |
| 2005.207 | Analgesic Efficacy and Pharmacokinetic of Ropivacaine Continuous Wound Instillation Following Hepatic Resection | Dr. Chan K.C. Simon |
| 2007.169 | Analgesic Effects of Auricular Transcutaneous Electrical Nerve Stimulation After Open Hysterectomy | Mr. Tsang Hin Cheung |
| 2007.469 | Anaesthesia-related Complication in Adult Passive Smokers | Professor LEE Anna |
| 2006.358 | Anaesthesia Related Mortality and Morbidity in Year 2000 to 2005 | CHAN TV Matthew |
| 2007.456 | An Uncontrolled Observational Study to Monitor Vascular Access on Haemodilaysis Patients in One Single Centre | RN Poon Ka Lai |
| 2015.398 | An ten-year retrospective review of the medical management of tubal ectopic pregnancy with methotrexate |
Dr. WONG Lo 黃露 |
| 2015.712 | An qualitative exploratory study on illness experience of people living with Parkinson’s Disease |
Miss. KWOK Yan Yan 郭欣欣 |
| 2015.416 | An Outcome study of hypnotherapy for patients with irritable bowel syndrome (IBS): A randomized controlled trial |
Prof. WU Justin Che Yuen 胡志遠 |
| 2008.074 | An Outcome Model of Personalized Medicine by Genetic Testing for Warfarin Therapy | Prof You Joyce |
| 2005.243 | An Outcome Evaluation Study of Postnatal Depression Early Intervention Program | LEE Tak Shing Dominic |
| 2018.320 | An Oral Exercise Training Software for Elders in Hong Kong |
Prof. LEE Kathy Yuet Sheung 李月裳 |
| 2011.383 | An Optimization of Sourcing, Culturing and Preservation Procedures for Development of Mesenchymal Stem Cell Banking | Prof. LI Gang |
| 2010.248 | An Optimization of Sourcing, Culturing and Preservation Procedures for Development of Adult Stem Cell Banking | Prof. LI Gang |
| 2004.023 | An Opinion Survey on the Knowledge of Dementia in Chinese Caregiver of Patients with Dementia | LAM Chiu Wa Linda |
| 2012.321 | An opinion Survey among frail elderly patients and their carers regarding their opinion about self-financed community care services | Dr MA HON MING |
| 2002.396 | An Open, Randomised, Comparative, Multicentre Phase IIIb-IV Trial of the Efficacy and Safety of Ketek (Telithromycin) 8000mg Once Daily Versus other Usually Prescribed Anti-bacterials in Treating Outpatients with Mild to Moderate Community Acquired Pneumonia, Acute Exacerbations of Chronic Bronchitis and Acute Sinusitis | Prof. Tong CF Michael |
| 2012.383 | An open-labelled study to investigate Deep Brain Stimulation as treatment for medically refractory epilepsy | Prof. POON Wai Sang |
| 2011.382 | An Open-Label, Single-arm. Phase I study of AEB071 (a Protein Kinase C Inhibitor) in Patients with CD79-mutant Diffuse Large B-Cell Lymphoma | Dr Wong Siu Ming, Raymond |
| 2013.608 | An open-label, single-arm, Phase Ib/II study of AEB071 (a protein kinase C inhibitor) and everolimus (mTOR inhibitor) in patients with CD79-mutant or ABC subtype diffuse large B-cell lymphoma | Dr. WONG Raymond Siu Ming |
| 2009.309 | An Open-label, Single-Arm, Phase 2 Study of Inotuzumab Ozogamicin Plus Rituximab in Subjects With Relapsed / Refractory CD22-Positive Diffuse Large B-Cell Lymphoma, Eligible for Autologous Stem Cell Transplantation | Dr. WONG Raymond Siu Ming |
| 2019.158 | An Open-Label, Single Arm Study to Evaluate the Efficacy and Safety of REGN3918 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Are Complement Inhibitor-Naive or Have Not Recently Received Complement Inhibitor Therapy |
Dr. WONG Raymond Siu Ming 王紹明 |
| 2007.447 | An Open-Label, Randomized, Phase 3 Study of Inotuzumab Ozogamicin(CMC-544) Administered in Combination with Rituximab Compared to A Defined Investigator | Dr. Lei Ieng Kit, Kenny |
| 2012.150 | An Open-Label, Randomized, Phase 2 Study to Access the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Patients with Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma | Dr. Wong Siu Ming Raymond |
| 2007.200 | An Open-Label, Randomized, Phase 2 Study of Efficacy and Tolerability of ABT-869 in Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | Prof. Mok S.K. Tony |
| 2008.099 | An Open-Label, Randomized, Multicenter, Parallel-group study to Demonstrate Correction of Anemia Using Once Every Four Weeks Subcutaneous Injections of RO0503821 in Patients with Chronic Kidney Disease Who are not on Dialysis | Prof. Kong Alice Pik-Shan |
| 2003.265 | An Open-Label, Randomized, Multi-Centre, Phase IIIb/IV, Parallel Group Study to Compare the Efficacy and Safety of Rosuvastatin and Atorvastatin in Subjects with Type IIa and IIb Hypercholesterolaemia | Prof. Brian Tomlinson |
| 2015.351 | An open-label, randomized, multi-center, single dose, two-period, two-sequence crossover study to investigate the bioequivalence of Peginterferon (PEG-IFN) alfa-2a benzyl alcohol-free formulation versus the reference market formulation following subcutaneous administration via prefilled syringe in healthy Chinese subjects |
Dr. OZAKI Risa Not applicable |
| 2010.563 | An open-label, randomized, multi-center, phase II study to compare the safety and efficacy of TKI258 versus sorafenib as first-line treatment in adult patients with advanced hepatocellular carcinoma | Assistant Professor Chan Lam, Stephen |
| 2020.055 | An Open-label, Randomized Phase 3 Study of MK-6482 Versus Everolimus in Participants with Advanced Renal Cell Carcinoma That Has Progressed After Prior PD-1/L1 and VEGF-Targeted Therapies | Dr. POON Darren Ming Chun |
| 2024.096 | An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination with Pembrolizumab Versus Treatment of Physician’s Choice in Participants with HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer | Prof. YEO Winnie |
| 2010.201 | An Open-label, Randomized Phase 3 Study of Efficacy and Tolerability of Linifanib (ABT-869) versus Sorafenib in Subjects with Advanced Hepatocellular Carcinoma (HCC) | Prof. Yeo Winnie |
Page 197 of 254.